• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

ERC grant: €2 million for synthetic biology at TU Darmstadt

Bioengineer by Bioengineer
December 8, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Darmstadt, December 8, 2017. The European Research Council awards an ERC Consolidator Grant to professor Heinz Koeppl and supports him for a period of five years with a total of two Million Euros. This will further strengthen the activities of TU Darmstadt in the domain of synthetic biology.

The prestigious ERC Consolidator Grant for Heinz Koeppl is linked to the project "CONSYN – Contextualizing biomolecular circuits models for synthetic biology". Its goal is to make the design of synthetic genetic circuits more reliable and more efficient through the use of computational modelling.

Synthetic biology is concerned with the integration of new molecular functionality inside biological cells. For instance, a genetic logic circuit can be integrated that can "decide" on the basis of a few intracellular markers whether a cell turns into a cancer cell or not. Even in the simplest model organisms, such as E. coli the integration of those circuits is experimentally very challenging. The circuit behaviour is hard to predict, because the intracellular environment affects the behaviour significantly. CONSYN aims to capture this context-dependency of circuits in computational models. Model building will rely on methods from stochastic analysis, statistical physics and machine learning.

In CONSYN such contextualised models then provide the starting point for a computer-aided circuit synthesis, similarly to microelectronics where such a synthesis is established for long already. Different circuit variants can be compared and optimised on the computer before an experimental realisation within a cell is started. CONSYN provides one more contribution to the focus area "synthetic biology" at TU Darmstadt that is currently pushed forward by the two LOEWE collaborative research efforts CompuGene and iNAPO.

###

Bio

Heinz Koeppl studied physics at Graz Karl-Franzens-University, Austria. In cooperation with Infineon Technologies he obtained his Ph.D. in electrical engineering at Graz University of Technology in 2004. After postdoc stays at UC Berkeley and École Polytechnique Fédérale de Lausanne (EPFL) he was appointed as an assistant professor at ETH Zurich, Switzerland. In 2013 he additionally founded and led the systems biology group at IBM Research Zurich. Since 2014, he leads the Bioinspired Communication Systems Lab at the Department of Electrical Engineering and Information Technology of TU Darmstadt. He is co-affiliated with the Department of Biology.

Further information: http://www.bcs.tu-darmstadt.de
http://www.compugene.tu-darmstadt.de

Media Contact

Dr. Heinz Koeppl
[email protected]
@TUDarmstadt

http://www.tu-darmstadt.de

Share12Tweet8Share2ShareShareShare2

Related Posts

Personalized Guide to Understanding and Reducing Chemicals

February 7, 2026

Inflammasome Protein ASC Drives Pancreatic Cancer Metabolism

February 7, 2026

Phage-Antibiotic Combo Beats Resistant Peritoneal Infection

February 7, 2026

Boosting Remote Healthcare: Stepped-Wedge Trial Insights

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Personalized Guide to Understanding and Reducing Chemicals

Inflammasome Protein ASC Drives Pancreatic Cancer Metabolism

Phage-Antibiotic Combo Beats Resistant Peritoneal Infection

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.